Department of Surgery, Fukuoka University Chikushi Hospital, Fukuoka, Japan
Department of Surgery, Fukuoka University Chikushi Hospital, Fukuoka, Japan.
Anticancer Res. 2024 Aug;44(8):3427-3441. doi: 10.21873/anticanres.17163.
BACKGROUND/AIM: Self-expandable metallic stent (SEMS) placement is becoming the standard bridge-to-surgery (BTS) strategy for potentially curable left-sided obstructive colorectal cancer (OCRC). The study objective was to evaluate the effectiveness of SEMS placement as a BTS strategy for both right- and left-sided OCRC.
We retrospectively compared the short- and long-term outcomes of patients with OCRC who underwent placement of a SEMS versus a trans-nasal/anal decompression tube (DCT). The cohort comprised 57 patients with stage II/III right-sided OCRC (DCT, n=20; SEMS, n=8) or left-sided OCRC (DCT, n=9; SEMS, n=20). The short-term outcomes were the incidence of postoperative complications, rate of laparoscopic surgery, rate of stoma construction, and postoperative hospital stay; long-term outcomes were the 3-year overall survival (OS) and relapse-free survival (RFS).
The SEMS group had a higher rate of laparoscopic surgery (85.7% vs. 6.9%, p<0.001), lower rate of stoma construction (10.7% vs. 34.5%, p=0.03), and shorter postoperative hospital stay (14 vs. 17 days, p=0.04) than the DCT group. Both groups had a similar incidence of postoperative complications. The 3-year OS and RFS were also similar in the DCT and SEMS groups for both right-sided OCRC (OS, 75.0% vs. 87.5%, HR=1.51, 95% CI=0.22-10.25, p=0.7; RFS, 65.0% vs. 50.0%, HR=0.97, 95% CI=0.28-3.36, p=0.9) and left-sided OCRC (OS, 88.8% vs. 90.0%, HR=1.19, 95% CI=0.10-14.29, p=0.9; RFS, 77.8% vs. 85.0%, HR=1.03, 95% CI=0.16-6.5, p=0.9).
SEMS placement is a reasonable BTS strategy for left- and right-sided OCRC that achieves comparable short- and long-term outcomes to DCT insertion.
背景/目的:自膨式金属支架(SEMS)置入术已成为可治愈的左侧梗阻性结直肠癌(OCRC)的标准桥接手术(BTS)策略。本研究的目的是评估 SEMS 置入术作为右侧和左侧 OCRC 的 BTS 策略的有效性。
我们回顾性比较了接受 SEMS 与经鼻/肛门减压管(DCT)置入的 OCRC 患者的短期和长期结局。该队列包括 57 例 II/III 期右侧 OCRC 患者(DCT 组 20 例;SEMS 组 8 例)或左侧 OCRC 患者(DCT 组 9 例;SEMS 组 20 例)。短期结局为术后并发症发生率、腹腔镜手术率、造口率和术后住院时间;长期结局为 3 年总生存率(OS)和无复发生存率(RFS)。
SEMS 组腹腔镜手术率(85.7% vs. 6.9%,p<0.001)、造口率(10.7% vs. 34.5%,p=0.03)和术后住院时间(14 天 vs. 17 天,p=0.04)均低于 DCT 组。两组术后并发症发生率相似。右侧 OCRC 患者的 3 年 OS(75.0% vs. 87.5%,HR=1.51,95%CI=0.22-10.25,p=0.7)和 RFS(65.0% vs. 50.0%,HR=0.97,95%CI=0.28-3.36,p=0.9)以及左侧 OCRC 患者的 OS(88.8% vs. 90.0%,HR=1.19,95%CI=0.10-14.29,p=0.9)和 RFS(77.8% vs. 85.0%,HR=1.03,95%CI=0.16-6.5,p=0.9)也相似。
SEMS 置入术是一种合理的左、右侧 OCRC 的 BTS 策略,其短期和长期结局与 DCT 置入术相当。